Melior Pharmaceuticals I, Inc. — Form D
Melior Pharmaceuticals I, Inc. of EXTON, PA, a company, filed a Form D exempt-offering notice with the SEC on 2011-10-07. The offering totals $375K, of which $375K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2011-10-07
- Form: D
- Accession: 0001532246-11-000001
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $375K
- Amount sold: $375K
- Minimum investment: $25K
- Investors: 5
- Date of first sale: 2011-09-26
- Security types: debt
- Revenue range: No Revenues
- SEC file number: 021-166899
Issuer
- Name: Melior Pharmaceuticals I, Inc.
- CIK: 0001532246
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2008
- Address: 860 SPRINGDALE DRIVE, EXTON, PA, 19341
- Phone: 610-280-0633
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Robert Adelson | Director | Boston, MA |
| Perry Molinoff | Director | DALLAS, TX |
| Toby Moskovits | Director | Exton, PA |
| Andrew Reaume | Director | Exton, PA |
| Michael Saporito | Director | Exton, PA |
| Jeffrey Vaught | Director | Exton, PA |
| Bobba Venkatadri | Director | Exton, PA |
| Andrew Reaume | Executive Officer | Exton, PA |
More